Clinical Trial Update: Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2? [Phase 3]

View source ↗

Summary

A Phase 3 trial investigated whether valacyclovir can attenuate inflammation in people with HIV on antiretroviral therapy who are co-infected with herpes simple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Infection
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Human Immunodeficiency Virus, Herpes Simplex | Phase 3 | Status: COMPLETED